First Allied Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,470
Closed -$253K 1133
2018
Q3
$253K Buy
+1,470
New +$253K 0.01% 988